Esperion Therapeutics (ESPR) Times Interest Earned: 2019-2025
Historic Times Interest Earned for Esperion Therapeutics (ESPR) over the last 6 years, with Sep 2025 value amounting to -$0.45.
- Esperion Therapeutics' Times Interest Earned rose 57.50% to -$0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.37, marking a year-over-year decrease of 231.85%. This contributed to the annual value of $0.92 for FY2024, which is 134.81% up from last year.
- Esperion Therapeutics' Times Interest Earned amounted to -$0.45 in Q3 2025, which was down 230.40% from $0.35 recorded in Q2 2025.
- In the past 5 years, Esperion Therapeutics' Times Interest Earned registered a high of $5.15 during Q1 2024, and its lowest value of -$10.19 during Q1 2021.
- Moreover, its 3-year median value for Times Interest Earned was -$1.06 (2024), whereas its average is -$0.71.
- Per our database at Business Quant, Esperion Therapeutics' Times Interest Earned skyrocketed by 252.53% in 2024 and then crashed by 122.07% in 2025.
- Over the past 5 years, Esperion Therapeutics' Times Interest Earned (Quarterly) stood at -$4.14 in 2021, then increased by 28.37% to -$2.97 in 2022, then grew by 5.16% to -$2.81 in 2023, then surged by 90.43% to -$0.27 in 2024, then surged by 57.50% to -$0.45 in 2025.
- Its Times Interest Earned stands at -$0.45 for Q3 2025, versus $0.35 for Q2 2025 and -$1.14 for Q1 2025.